Every material Form 8-K Newegg Commerce, Inc. has filed with the SEC since January 04, 2013, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Newegg Commerce disclosed that on April 23, 2013 it determined it qualifies as a foreign private issuer under Exchange Act Rule 3b-4, and it will begin reporting as one effective immediately after this filing. The filing says it will file annual reports on Form 20-F and current reports on Form 6-K. The signature block names Dehaier Medical Systems Limited and Ping Chen as CEO, which does not match the Newegg name in the filing details, so the registrant's identity should be confirmed. The change affects reporting obligations and does not include any financial results.
Determination date: April 23, 2013
Status effective immediately after the filing of this Form 8-K
Future reports: annual report on Form 20-F and current reports on Form 6-K
Signature block names Dehaier Medical Systems Limited and CEO Ping Chen, which differs from the Newegg name in the filing details
Dehaier Medical Systems Limited said its chief financial officer, Charles Li, was appointed to its board effective March 30, 2013, and director Weibing Yang resigned the same day. The filing states Yang's resignation was not due to any disagreement with the company, and Li will receive no extra pay for board service. The filing names Dehaier Medical Systems Limited, not Newegg Commerce, so this summary covers the Dehaier filing.
Charles Li, 27, appointed to the board effective March 30, 2013, as a Class II member until the 2015 shareholder meeting
Li is also chief financial officer and will receive no director compensation beyond his CFO pay
Weibing Yang resigned as a director effective March 30, 2013; the filing says there was no disagreement
Dehaier Medical Systems Limited (NASDAQ: DHRM) said its internal promotions took effect December 28, 2012, naming Charles (Jingli) Li as Chief Financial Officer, the principal financial and accounting officer, and moving Aileen (Yanying) Qi from that role to Vice President. The filing is attributed to Dehaier Medical, not Newegg, and it does not mention Newegg or the NEGG ticker. The filing contains no financial results, guidance, or compensation terms, so it gives shareholders no direct financial figures.
Charles (Jingli) Li, age 27, moved from Internal Controls Manager to CFO effective December 28, 2012
Aileen (Yanying) Qi moved from CFO to Vice President effective December 28, 2012
The 8-K reports no financial results, guidance, or compensation terms
Filer is Dehaier Medical Systems Limited (NASDAQ: DHRM), which does not match the NEGG ticker in the request
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Newegg Commerce, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →